Please use this identifier to cite or link to this item: http://hdl.handle.net/11434/754
Title: Management of male pattern hair loss.
Epworth Authors: Sinclair, Rodney
Keywords: Administration
Adult
Aged
Alopecia
Pathology
Therapy
Enzyme Inhibitors
Therapeutic Use
Finasteride
Hair Transplantation
Male
Minoxidil
Vasodilator Agents
Androgenetic Alopecia
AGA
Male Pattern Baldness
Male Pattern Hair Loss
Department of Dermatology, Epworth Hospital, Richmond, Victoria, Australia
Issue Date: Jul-2001
Publisher: Frontline Medical Communications Inc.
Citation: Cutis. 2001 Jul;68(1):35-40.
Abstract: The management of androgenetic alopecia (AGA) has been materially altered by the availability of the 5 alpha-reductase type 2 inhibitor, finasteride. Nevertheless, this agent is only one component of successful management, and an understanding of the role of camouflage agents, surgical options, and other medical treatments is important. Because no treatment completely reverses baldness, it is important to communicate the limitations of each modality to the patient so that he has appropriate expectations of the outcome of any intervention. Patient counseling and support are also often relevant.
URI: http://hdl.handle.net/11434/754
PubMed URL: http://www.ncbi.nlm.nih.gov/pubmed/11480145
ISSN: 0011-4162
Journal Title: Cutis
Type: Journal Article
Type of Clinical Study or Trial: Review
Appears in Collections:Head & Neck
Dermatology

Files in This Item:
There are no files associated with this item.


Items in EKB are protected by copyright, with all rights reserved, unless otherwise indicated.